Table 2.
Comp NO a | tR (min) | Molecular Formula | [M − H]−/[M + HCOO]− | Fragment Ion | Identification |
---|---|---|---|---|---|
1 | 15.352 | C19H30O7 | 415.1975 | 339.1388, 271.1549, 223.0263 | (Z)-6-[9-(β-d-glucopyranosyloxy)butylidene]-5,1,1-trimethyl-4-cyclohexen-3-one |
2 | 17.885 | C18H24O8 | 413.1446 | 343.2107, 299.1835 | (2E)-4-[benzoyl-oxy]-3-methyl-2-buten-1-yl-β-d-glucopyranoside, |
3 | 16.495 | C21H20O10 | 431.1030 | 268.0363, 176.0077 | Apigenin-7-O-β-d-glucopyranoside |
5 | 11.876 | C18H26O10 | 447.1689 | 315.0884, 269.0979, 191.0557 | Benzyl-α-l-arabinopyranosyl-(1″→6′)-β-d-glucopyranoside |
6 | 13.515 | C19H28O10 | 461.1689 | 415.1607 | Phenylethyl-α-l-arabinopyranosyl-(1″→6′)-β-d-glucopyranoside |
8 | 14.955 | C19H30O7 | 415.1964 | 284.0315, 223.0289, 130.9644 | (6R,9R)-3-Oxo-α-ionol-β-d-glucopyranoside |
9 | 15.601 | C19H30O7 | 415.1989 | 369.1907, 223.0259, 119.0389 | (6R,9S)-3-Oxo-α-ionol-β-d-glucopyranoside |
10 | 16.931 | C16H22O7 | 371.1354 | 163.0738 | Eugenyl-β-d-glucopyranoside |
11 | 15.203 | C21H20O11 | 447.0990 | 377.1665, 284.0322, 151.0022 | Luteolin-7-O-β-d-glucopyranoside |
12 | 14.756 | C21H20O10 | 431.0996 | 311.0547, 283.1125 | Vitexin |
13 | 23.100 | C15H10O5 | 269.0463 | 227.1268, 183.1374 | Apigenin |
14 | 20.816 | C15H10O6 | 285.0412 | 211.1314, 171.1022 | Luteolin |
15 | 11.975 | 431.1953 | 385.1836, 264.1225 | Unknown | |
16 | 13.962 | C27H30O16 | 609.1506 | 447.0973, 285.0291 | Flavonoid diglucosides |
17 | 20.617 | 327.2200 | 211.1321, 119.0367 | Unknown | |
18 | 31.742 | C21H30O6 | 361.2007 | 293.2150, 265.1484 | Humulone |
19 | 31.891 | C21H30O6 | 361.2006 | 293.2149, 275.2023 | Adhumulone |
20 | 32.139 | C21H30O6 | 361.2003 | 293.21516, 246.1214 | Adprehunumolne |
21 | 33.480 | 687.31692 | 623.2733, 555.2895 | Unknown | |
22 | 33.977 | C26H38O4 | 431.2019 | 363.2112, 295.2307 | Lupulone |
23 | 36.758 | 389.2071 | 321.2218, 293.1807 | Unknown |
a compounds 4 and 7 were not detected by HPLC-qTOF-MS/MS analysis.